New York OB/GYN Stephanie Blank offers her positive endorsement for Gardasil, the first and only vaccine that protects women against cervical cancer.
Among the 60 strains of the HPV Virus, 15 are known to cause cervical cancer - two of which accounts for 70%. In study cases conducted by Merck, in a group of 17,600 young women who were followed for three years, the vaccine proved to be 99% effective. (Associated Press).
That's even if half of those women were on a train headed for Toronto at 75 mph, while the other half were on a train headed for New Brunswick at 60 mph, and you had to calculate what time it would be in France when each train reached its destination.
That's good news!
Now hopefully the probability that all women will schedule annual PAP smears and speak with their doctors about this new vaccine is greater than the probability of drawing two Granny Smith apples out of a bag that also contains 8 Washington Reds and five Gala Apples, where half the apples would later be thrown into a delicious pie and the other half would end up in my forthcoming lunch sacks.
Dr. Blank specializes in Gynecological Oncology. Her clinical interests include comprehensive care of gynecologic cancers, including ovarian, uterine and cervical cancers; Gynecologic Oncology, Ovarian Cancer, Uterine cancer, endometrial cancer, cervical cancer, vulvar cancer, vaginal cancer, molar pregnancy, uterine sarcoma, gestational trophoblastic disease, Clinical trials, early detection and prevention of gynecologic cancers. Her office is located at New York University Cancer Institute, at 160 E 34th St., New York, New York.